| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| GTO ID | GTC2339 |
| Trial ID | NCT04322292 |
| Disease | Multiple Myeloma |
| Altered gene | BCMA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | C-CAR088 |
| Phase | Phase1 |
| Recruitment status | Unknown |
| Title | A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma |
| Year | 2019 |
| Country | China |
| Company sponsor | Institute of Hematology & Blood Diseases Hospital |
| Other ID(s) | QT-2019007-EC-2 |
| Vector information | |||||
|
|||||
| Cohort1: low dose | |||||||||||
|
|||||||||||
| Cohort2: medium dose | |||||||||||
|
|||||||||||
| Cohort3: high dose | |||||||||||
|
|||||||||||